Please use this identifier to cite or link to this item:
Title: Serum 25-Hydroxyvitamin D Insufficiency in Search of a Bone Disease.
Austin Authors: Shah, Sonali;Chiang, Cherie Y ;Sikaris, Ken;Lu, Zhong;Bui, Minh;Zebaze, Roger M D;Seeman, Ego 
Affiliation: Melbourne Pathology, Melbourne, Australia
Institute for Health and Aging, Australian Catholic University, Melbourne, Australia
Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia
Issue Date: 1-Jul-2017
Publication information: The Journal of Clinical Endocrinology and Metabolism 2017; 102(7): 2321-2328
Abstract: Vitamin D "insufficiency" and "deficiency" are defined as serum 25-hydroxyvitamin D [25(OH)D] levels <75 and <30 nmol/L, respectively. We aimed to determine whether these values signal hypocalcemia and hypophosphatemia, secondary hyperparathyroidism, high bone remodeling, low areal bone mineral density (aBMD), microstructural deterioration, or reduced matrix mineralization density (MMD) and so suggest whether bone fragility is present. Concentrations of 25(OH)D, calcium, phosphate, creatinine, and parathyroid hormone (PTH) were measured in 11,855 participants. Serum C-terminal telopeptide of type 1 collagen, procollagen type 1 N-terminal propeptide (P1NP), aBMD, and distal radius microstructure and MMD were measured in a second subset of 150 participants. A breakpoint for calcium, PTH, and alkaline phosphatase was identified at a threshold 25(OH)D level <30 nmol/L. There was no plateau beyond 75 nmol/L. In the subgroup with measurements of bone morphology, no associations were detectable between serum 25(OH)D concentration, aBMD, trabecular density, cortical porosity, or MMD. Among 1439 participants with serum 25(OH)D <30 nmol/L, 6.1% had low serum calcium, 3.4% had low serum phosphate, 6.1% had high alkaline phosphatase, and 34.2% had elevated PTH. Most participants did not have any abnormalities. At a 25(OH)D threshold of ≤30 nmol/L, abnormalities in biochemical features support the notion of a "deficiency" state predisposing to bone disease. However, no deleterious effects were found in participants within an insufficiency threshold of a 25(OH)D level of 30 to 75 nmol/L, which challenges the rationale justifying vitamin D supplementation in these individuals.
DOI: 10.1210/jc.2016-3189
ORCID: 0000-0002-9392-6771
Journal: The Journal of Clinical Endocrinology and Metabolism
PubMed URL: 28379394
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jun 17, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.